Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

NASDAQ:VERA

Overview | Financials
Company Name Vera Therapeutics, Inc.
Symbol VERA
Currency USD
Price 28.36
Market Cap 1,795,843,116
Dividend Yield 0%
52-week-range 25.99 - 51.61
Industry Biotechnology
Sector Healthcare
CEO Dr. Marshall Fordyce M.D.
Website https://veratx.com

An error occurred while fetching data.

About Vera Therapeutics, Inc.

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A

Related Stocks

908 Devices Inc. logo

908 Devices Inc.

MASS

3.46 USD

Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

BNGO

3.67 USD

CareMax, Inc. logo

CareMax, Inc.

CMAX

0.422 USD

Cara Therapeutics, Inc. logo

Cara Therapeutics, Inc.

CARA

5.125 USD

Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc.

ARCT

13.21 USD

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

2.6 USD

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

8.66 USD

2seventy bio, Inc. logo

2seventy bio, Inc.

TSVT

4.95 USD

Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc.

NAUT

1.13 USD

Financials

Numbers are in millions USD

Numbers are in millions USD